C182H167Cl2N35O14S2 — CID 159343885
N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,6-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;methane;N-[4-[6-[(2-phenylcyclopropanecarbonyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;bis(N-[4-[6-(thiophene-3-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide) (PubChem CID 159343885) has the molecular formula C182H167Cl2N35O14S2 and a molecular weight of 3203.61 g/mol. Its IUPAC name is N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,6-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;methane;N-[4-[6-[(2-phenylcyclopropanecarbonyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;bis(N-[4-[6-(thiophene-3-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide).
| Compound Name | N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,6-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;methane;N-[4-[6-[(2-phenylcyclopropanecarbonyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;bis(N-[4-[6-(thiophene-3-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide) |
|---|---|
| PubChem CID | 159343885 |
| Molecular Formula | C182H167Cl2N35O14S2 |
| Molecular Weight | 3203.61 g/mol |
| Exact Mass | 3200.23 |
| IUPAC Name | N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,6-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;methane;N-[4-[6-[(2-phenylcyclopropanecarbonyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;bis(N-[4-[6-(thiophene-3-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide) |
| SMILES | C.C.C.C.C.C.C.CC(=O)Nc1ccc2nc(-c3ccc(NC(=O)c4cccnc4)cc3)[nH]c2c1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CC4c4ccccc4)cc3[nH]2)cc1)c1cccnc1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CCCC4)cc3[nH]2)cc1)c1cccnc1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CCCCC4)cc3[nH]2)cc1)c1cccnc1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)c4c(Cl)cccc4Cl)cc3[nH]2)cc1)c1cccnc1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)c4ccsc4)cc3[nH]2)cc1)c1cccnc1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)c4ccsc4)cc3[nH]2)cc1)c1cccnc1 |
| InChI | InChI=1S/C29H23N5O2.C26H17Cl2N5O2.C26H25N5O2.C25H23N5O2.2C24H17N5O2S.C21H17N5O2.7CH4/c35-28(20-7-4-14-30-17-20)31-21-10-8-19(9-11-21)27-33-25-13-12-22(15-26(25)34-27)32-29(36)24-16-23(24)18-5-2-1-3-6-18;27-19-4-1-5-20(28)23(19)26(35)31-18-10-11-21-22(13-18)33-24(32-21)15-6-8-17(9-7-15)30-25(34)16-3-2-12-29-14-16;32-25(18-5-2-1-3-6-18)29-21-12-13-22-23(15-21)31-24(30-22)17-8-10-20(11-9-17)28-26(33)19-7-4-14-27-16-19;31-24(17-4-1-2-5-17)28-20-11-12-21-22(14-20)30-23(29-21)16-7-9-19(10-8-16)27-25(32)18-6-3-13-26-15-18;2*30-23(16-2-1-10-25-13-16)26-18-5-3-15(4-6-18)22-28-20-8-7-19(12-21(20)29-22)27-24(31)17-9-11-32-14-17;1-13(27)23-17-8-9-18-19(11-17)26-20(25-18)14-4-6-16(7-5-14)24-21(28)15-3-2-10-22-12-15;;;;;;;/h1-15,17,23-24H,16H2,(H,31,35)(H,32,36)(H,33,34);1-14H,(H,30,34)(H,31,35)(H,32,33);4,7-16,18H,1-3,5-6H2,(H,28,33)(H,29,32)(H,30,31);3,6-15,17H,1-2,4-5H2,(H,27,32)(H,28,31)(H,29,30);2*1-14H,(H,26,30)(H,27,31)(H,28,29);2-12H,1H3,(H,23,27)(H,24,28)(H,25,26);7*1H4 |
| InChIKey | LGLZSMPPGNYEIB-UHFFFAOYSA-N |
| XLogP | 41.13 |
| TPSA | 698.39 Ų |
| H-Bond Donors | 21 |
| H-Bond Acceptors | 30 |
| Rotatable Bonds | 35 |
| Heavy Atoms | 235 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3203.61 |
| LogP ≤ 5 | 41.13 |
| H-Bond Donors ≤ 5 | 21 |
| H-Bond Acceptors ≤ 10 | 30 |